Previous 10 | Next 10 |
VolitionRx (NYSE American: VNRX) is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. ...
A look at the top 10 most actives in the United States Cyngn Inc. (CYN) fell 5.8% to $0.114 on volume of 321,909,962 shares Pineapple Energy Inc. (PEGY) rose 23.6% to $0.0566 on volume of 180,092,924 shares NewGenIvf Group Limited (NIVF) rose 74.2% to $2.23 on volume of 136,563,105 shares...
Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech PR Newswire HENDERSON, Nev. , April 23, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu...
2024-03-26 12:43:06 ET VolitionRx Limited (VNRX) Q4 2023 Results Conference Call March 26, 2024 08:30 AM ET Company Participants Louise Batchelor - Chief Marketing and Communications Officer Cameron Reynolds - President and Group Chief Executive Officer Terig Hug...
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , Marc...
2024-03-24 17:35:00 ET Major earnings expected after the bell on Monday include: Westport Fuel Systems ( WPRT ) Bakkt Holdings ( BKKT ) TMC the metals company ( TMC ) Dada Nexus Limited ( DADA ) Read the full article on Seeking Alpha For furth...
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Tuesday March 26 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev. , March 21, 2024 /PRNewswire/ -- V...
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan PR Newswire HENDERSON, Nev. , March 20, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has agreed a supply agreement with F...
2024-03-20 03:19:54 ET More on VolitionRX Seeking Alpha’s Quant Rating on VolitionRX Historical earnings data for VolitionRX Financial information for VolitionRX Read the full article on Seeking Alpha For further details see: Volition appoi...
Volition appoints Dr Andrew Retter as Chief Medical Officer PR Newswire HENDERSON, Nev. , March 19, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Dr Andrew Retter as its Ch...
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...